NEW YORK — Kroger Health said on Tuesday that it has signed an agreement to offer Gauss' smartphone-enabled, at-home COVID-19 Rapid Antigen Test Kit throughout the US.
Kroger Health said that it will offer the kit online and at the counters of its 2,200 pharmacies nationwide once it has received Emergency Use Authorization from the US Food and Drug Administration.
The kit, developed by Gauss in collaboration with Cellex, uses a smartphone app to instruct an individual on how to collect a nasal swab sample and perform the lateral flow assay. After 15 minutes, the app prompts the individual to scan the test to obtain a result. The app also shares the test result with appropriate public health agencies.Â
Menlo Park, California-based Guass has already produced 1.5 million of the kits and has the capacity to produce up to 30 million monthly, Kroger Health added.
Kroger Health, the healthcare arm of Cincinnati, Ohio-based retail company Kroger, received EUA from the FDA for an at-home nasal swab specimen collection kit for SARS-CoV-2 testing in mid-2020.
Â